Literature DB >> 34674055

The Importance of Primary Care in Cardio-Oncology.

Daniel A Cehic1,2, Aaron L Sverdlov3,4,5,6, Bogda Koczwara7,8, Jon Emery9, Doan T M Ngo5,6,10, Elysia Thornton-Benko11,12.   

Abstract

OPINION STATEMENT: There is significant interplay between cancer and cardiovascular disease involving shared risk factors, cross disease communication where cardiovascular events can influence cancer recurrence, and mortality rates and cardiotoxicity from cancer treatments with resultant increased cardiovascular mortality and morbidity in cancer patients. This is a major cause of death in many long-term cancer survivors. As a result, cardio-oncology, which involves the prevention, early detection, and optimal treatment of cardiovascular disease in patients treated for cancer, is expanding globally. However, there is still limited awareness of its importance and limited application of the lessons already learnt. Primary care physicians, and their clinical teams, especially nursing colleagues, have a foundation role in the management of all patients, and this paper outlines areas where they can lead in the cardio-oncology management of cancer patients. Although there is currently a lack of an adequate clinical framework or shared care plan, primary care physicians have a role to play in the various phases of cancer treatment: pre-therapy, during therapy, and survivorship.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cancer; Cardio-oncology; Cardiovascular; Primary Care

Mesh:

Year:  2021        PMID: 34674055     DOI: 10.1007/s11864-021-00908-2

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  91 in total

Review 1.  CDK 4/6 Inhibitors in Breast Cancer: Current Controversies and Future Directions.

Authors:  Laura M Spring; Seth A Wander; Mark Zangardi; Aditya Bardia
Journal:  Curr Oncol Rep       Date:  2019-02-26       Impact factor: 5.075

2.  The global cancer burden: necessity is the mother of prevention.

Authors:  Christopher P Wild
Journal:  Nat Rev Cancer       Date:  2019-03       Impact factor: 60.716

3.  Modifiable risk factors and major cardiac events among adult survivors of childhood cancer.

Authors:  Gregory T Armstrong; Kevin C Oeffinger; Yan Chen; Toana Kawashima; Yutaka Yasui; Wendy Leisenring; Marilyn Stovall; Eric J Chow; Charles A Sklar; Daniel A Mulrooney; Ann C Mertens; William Border; Jean-Bernard Durand; Leslie L Robison; Lillian R Meacham
Journal:  J Clin Oncol       Date:  2013-09-03       Impact factor: 44.544

4.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Authors:  Hyuna Sung; Jacques Ferlay; Rebecca L Siegel; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  CA Cancer J Clin       Date:  2021-02-04       Impact factor: 508.702

Review 5.  Trastuzumab-Induced Cardiomyopathy.

Authors:  Rachel Barish; Emily Gates; Ana Barac
Journal:  Cardiol Clin       Date:  2019-08-27       Impact factor: 2.213

Review 6.  Global Cancer Incidence and Mortality Rates and Trends--An Update.

Authors:  Lindsey A Torre; Rebecca L Siegel; Elizabeth M Ward; Ahmedin Jemal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-12-14       Impact factor: 4.254

Review 7.  Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance.

Authors:  Nazanin Aghel; Diego Hernan Delgado; Jeffrey Howard Lipton
Journal:  Vasc Health Risk Manag       Date:  2017-08-04

8.  Trends in Participation Rates for the National Cancer Screening Program in Korea, 2002-2012.

Authors:  Mina Suh; Seolhee Song; Ha Na Cho; Boyoung Park; Jae Kwan Jun; Eunji Choi; Yeol Kim; Kui Son Choi
Journal:  Cancer Res Treat       Date:  2016-11-11       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.